Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In the past 3 months, 7 different studies have Independently described a close association between an activating JAK2 mutation (JAK2V617F) and the classic bcr/abi-negative MPD (ie, polycythemia vera, essential thrombocythemia, myelofibrosis with myeloid metaplasia) as well as the less frequent occurrence of the same mutation in both atypical MPD and the myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP453240.RAain2h9YfdwtRVBkMHxNx4w7FHU5jBaE07Gwx_zjL4jw130_assertion description "[In the past 3 months, 7 different studies have Independently described a close association between an activating JAK2 mutation (JAK2V617F) and the classic bcr/abi-negative MPD (ie, polycythemia vera, essential thrombocythemia, myelofibrosis with myeloid metaplasia) as well as the less frequent occurrence of the same mutation in both atypical MPD and the myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP453240.RAain2h9YfdwtRVBkMHxNx4w7FHU5jBaE07Gwx_zjL4jw130_provenance.
• NP317059.RAFNzIpXuF3m8uvk7jHjyotq5cWYYCfmEyuFhfxOk-iX4130_assertion description "[In the past 3 months, 7 different studies have Independently described a close association between an activating JAK2 mutation (JAK2V617F) and the classic bcr/abi-negative MPD (ie, polycythemia vera, essential thrombocythemia, myelofibrosis with myeloid metaplasia) as well as the less frequent occurrence of the same mutation in both atypical MPD and the myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP317059.RAFNzIpXuF3m8uvk7jHjyotq5cWYYCfmEyuFhfxOk-iX4130_provenance.
• NP585191.RA1_EYXuvpVFVy423mmgjN23EFe07Jd0pk7oJilhjaXhM130_assertion description "[In the past 3 months, 7 different studies have Independently described a close association between an activating JAK2 mutation (JAK2V617F) and the classic bcr/abi-negative MPD (ie, polycythemia vera, essential thrombocythemia, myelofibrosis with myeloid metaplasia) as well as the less frequent occurrence of the same mutation in both atypical MPD and the myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP585191.RA1_EYXuvpVFVy423mmgjN23EFe07Jd0pk7oJilhjaXhM130_provenance.
• NP896841.RACpIFXv2nXFoDnqAjwdUSUSlVHU06ptu6Akjhbv8i-vg130_assertion description "[In the past 3 months, 7 different studies have Independently described a close association between an activating JAK2 mutation (JAK2V617F) and the classic bcr/abi-negative MPD (ie, polycythemia vera, essential thrombocythemia, myelofibrosis with myeloid metaplasia) as well as the less frequent occurrence of the same mutation in both atypical MPD and the myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP896841.RACpIFXv2nXFoDnqAjwdUSUSlVHU06ptu6Akjhbv8i-vg130_provenance.
• NP503483.RACcnEHLZ7r5SWBYIlACIp7aWKJ-z3k9WaBW7TpsTpjD4130_assertion description "[In the past 3 months, 7 different studies have Independently described a close association between an activating JAK2 mutation (JAK2V617F) and the classic bcr/abi-negative MPD (ie, polycythemia vera, essential thrombocythemia, myelofibrosis with myeloid metaplasia) as well as the less frequent occurrence of the same mutation in both atypical MPD and the myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP503483.RACcnEHLZ7r5SWBYIlACIp7aWKJ-z3k9WaBW7TpsTpjD4130_provenance.
• NP503484.RADNOWZuFfkgvW51gz9OMLQ6VKWVRDbRAtzU2OhtD2wwU130_assertion description "[In the past 3 months, 7 different studies have Independently described a close association between an activating JAK2 mutation (JAK2V617F) and the classic bcr/abi-negative MPD (ie, polycythemia vera, essential thrombocythemia, myelofibrosis with myeloid metaplasia) as well as the less frequent occurrence of the same mutation in both atypical MPD and the myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP503484.RADNOWZuFfkgvW51gz9OMLQ6VKWVRDbRAtzU2OhtD2wwU130_provenance.
• NP503485.RAD0lCJeJztKm6zP0Aojn_8YHzsgzQ-Fcc-L8lhwcO7lc130_assertion description "[In the past 3 months, 7 different studies have Independently described a close association between an activating JAK2 mutation (JAK2V617F) and the classic bcr/abi-negative MPD (ie, polycythemia vera, essential thrombocythemia, myelofibrosis with myeloid metaplasia) as well as the less frequent occurrence of the same mutation in both atypical MPD and the myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP503485.RAD0lCJeJztKm6zP0Aojn_8YHzsgzQ-Fcc-L8lhwcO7lc130_provenance.
• NP503486.RAAIWL-drZcsKwe9_3nXOOUgiMeibGV1iWotCoMrJbK3w130_assertion description "[In the past 3 months, 7 different studies have Independently described a close association between an activating JAK2 mutation (JAK2V617F) and the classic bcr/abi-negative MPD (ie, polycythemia vera, essential thrombocythemia, myelofibrosis with myeloid metaplasia) as well as the less frequent occurrence of the same mutation in both atypical MPD and the myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP503486.RAAIWL-drZcsKwe9_3nXOOUgiMeibGV1iWotCoMrJbK3w130_provenance.
• NP519413.RA3EmcdbcSwpmjP7wOJBWhjpOTav7uJv2cerWQTFJDoGg130_assertion description "[In the past 3 months, 7 different studies have Independently described a close association between an activating JAK2 mutation (JAK2V617F) and the classic bcr/abi-negative MPD (ie, polycythemia vera, essential thrombocythemia, myelofibrosis with myeloid metaplasia) as well as the less frequent occurrence of the same mutation in both atypical MPD and the myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP519413.RA3EmcdbcSwpmjP7wOJBWhjpOTav7uJv2cerWQTFJDoGg130_provenance.
• NP896798.RA_Nizf_0KmmW8y260styFZ35r6qoo0c6Y_BSjM4kuapM130_assertion description "[In the past 3 months, 7 different studies have Independently described a close association between an activating JAK2 mutation (JAK2V617F) and the classic bcr/abi-negative MPD (ie, polycythemia vera, essential thrombocythemia, myelofibrosis with myeloid metaplasia) as well as the less frequent occurrence of the same mutation in both atypical MPD and the myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP896798.RA_Nizf_0KmmW8y260styFZ35r6qoo0c6Y_BSjM4kuapM130_provenance.
• assertion description "[In the past 3 months, 7 different studies have Independently described a close association between an activating JAK2 mutation (JAK2V617F) and the classic bcr/abi-negative MPD (ie, polycythemia vera, essential thrombocythemia, myelofibrosis with myeloid metaplasia) as well as the less frequent occurrence of the same mutation in both atypical MPD and the myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In the past 3 months, 7 different studies have Independently described a close association between an activating JAK2 mutation (JAK2V617F) and the classic bcr/abi-negative MPD (ie, polycythemia vera, essential thrombocythemia, myelofibrosis with myeloid metaplasia) as well as the less frequent occurrence of the same mutation in both atypical MPD and the myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In the past 3 months, 7 different studies have Independently described a close association between an activating JAK2 mutation (JAK2V617F) and the classic bcr/abi-negative MPD (ie, polycythemia vera, essential thrombocythemia, myelofibrosis with myeloid metaplasia) as well as the less frequent occurrence of the same mutation in both atypical MPD and the myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP503487.RAKMl69ehIPOocOv5QjXDgcxbkHZKZBg4Y3EUajiZg0zg130_assertion description "[In the past 3 months, 7 different studies have Independently described a close association between an activating JAK2 mutation (JAK2V617F) and the classic bcr/abi-negative MPD (ie, polycythemia vera, essential thrombocythemia, myelofibrosis with myeloid metaplasia) as well as the less frequent occurrence of the same mutation in both atypical MPD and the myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP503487.RAKMl69ehIPOocOv5QjXDgcxbkHZKZBg4Y3EUajiZg0zg130_provenance.
• NP519790.RAkWLbjjdO6fPKJeA9zVUhuzEXe6TyhgtG-8K2TMe04B8130_assertion description "[In the past 3 months, 7 different studies have Independently described a close association between an activating JAK2 mutation (JAK2V617F) and the classic bcr/abi-negative MPD (ie, polycythemia vera, essential thrombocythemia, myelofibrosis with myeloid metaplasia) as well as the less frequent occurrence of the same mutation in both atypical MPD and the myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP519790.RAkWLbjjdO6fPKJeA9zVUhuzEXe6TyhgtG-8K2TMe04B8130_provenance.
• NP896793.RAkTe7fD_AmRtLMFql6a6vJ_YZEgMKk0EJoM2PYnZZMW0130_assertion description "[In the past 3 months, 7 different studies have Independently described a close association between an activating JAK2 mutation (JAK2V617F) and the classic bcr/abi-negative MPD (ie, polycythemia vera, essential thrombocythemia, myelofibrosis with myeloid metaplasia) as well as the less frequent occurrence of the same mutation in both atypical MPD and the myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP896793.RAkTe7fD_AmRtLMFql6a6vJ_YZEgMKk0EJoM2PYnZZMW0130_provenance.
• NP896794.RAohTOWpIGlXG1BhSsDxUT6EU9B2p8-kDiHVCVSNAlIfs130_assertion description "[In the past 3 months, 7 different studies have Independently described a close association between an activating JAK2 mutation (JAK2V617F) and the classic bcr/abi-negative MPD (ie, polycythemia vera, essential thrombocythemia, myelofibrosis with myeloid metaplasia) as well as the less frequent occurrence of the same mutation in both atypical MPD and the myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP896794.RAohTOWpIGlXG1BhSsDxUT6EU9B2p8-kDiHVCVSNAlIfs130_provenance.
• NP503482.RAoY65_2fe0bqvs-50IPcezjrKFOiQc0JNmaU1xYZTzqY130_assertion description "[In the past 3 months, 7 different studies have Independently described a close association between an activating JAK2 mutation (JAK2V617F) and the classic bcr/abi-negative MPD (ie, polycythemia vera, essential thrombocythemia, myelofibrosis with myeloid metaplasia) as well as the less frequent occurrence of the same mutation in both atypical MPD and the myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP503482.RAoY65_2fe0bqvs-50IPcezjrKFOiQc0JNmaU1xYZTzqY130_provenance.